Skip to main content
padlock icon - secure page this page is secure

Conjugation Strategies for Colonic Delivery and its Application in Colorectal Cancer Therapy

Buy Article:

$68.00 + tax (Refund Policy)

Background: Efficient colon-specific drug delivery has been demonstrated recently in the treatment of various diseases, including Crohn's disease, ulcerative colitis (inflammatory bowel disease), and colorectal cancer.

Methods: Of all strategies, the conjugation of a model drug to a carrier (with or without spacers) has been recognized as promising for targeting the colon.

Results: This is because the conjugation method releases large amounts of the drug while reducing the amount of the drug released in the stomach and small intestine.

Conclusion: This review focuses on the design of linkage conjugates that carry out specific delivery to the colon. The types of conjugation for application in colorectal cancer therapy will be discussed as well.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: Colon-specific delivery; colorectal cancer; conjugate; drug delivery; linkage conjugates; targeting

Document Type: Review Article

Publication date: November 1, 2017

This article was made available online on November 13, 2017 as a Fast Track article with title: "Conjugation Strategies for Colonic Delivery and its Applicationin Colorectal Cancer Therapy".

More about this publication?
  • Current Drug Metabolism aims to cover all the latest and outstanding developments in drug metabolism and disposition. The journal serves as an international forum for the publication of timely reviews in drug metabolism. Current Drug Metabolism is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments. The journal covers the following areas:

    In vitro systems including CYP-450; enzyme induction and inhibition; drug-drug interactions and enzyme kinetics; pharmacokinetics, toxicokinetics, species scaling and extrapolations; P-glycoprotein and transport carriers; target organ toxicity and interindividual variability; drug metabolism and disposition studies; extrahepatic metabolism; phase I and phase II metabolism; recent developments for the identification of drug metabolites and adducts.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more